| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.0M | — | -10.8% |
| Cost of Revenue | $18.1M | — | -17.4% |
| Gross Profit | $10.9M | — | +3.0% |
| R&D Expense | $6.6M | — | -42.0% |
| SG&A Expense | $8.7M | — | -36.1% |
| Operating Income | -$14.2M | — | +32.8% |
| Pre-tax Income | -$18.8M | — | +24.6% |
| Income Tax | $112K | — | +93.1% |
| Net Income | -$18.9M | — | +24.3% |
| EPS (Basic) | -$2.22 | — | -1380.0% |
| EPS (Diluted) | -$2.22 | — | -1380.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.6M | -25.2% | -37.5% |
| Accounts Receivable | $33.3M | -13.1% | -4.0% |
| Inventory | $5.7M | +24.2% | -35.5% |
| Current Assets | $85.3M | -14.8% | -22.9% |
| Total Assets | $281.9M | -8.7% | -30.4% |
| Current Liabilities | $101.3M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.3M | — | -197.4% |
| Investing Cash Flow | -$1.3M | — | +62.5% |
| Financing Cash Flow | -$2.8M | — | +0.5% |
| -15.7% |
| Total Liabilities | $547.8M | -1.8% | -33.4% |
| Stockholders' Equity | -$266.3M | -6.7% | +36.2% |